Research and Markets (http://www.researchandmarkets.com/research/x2zbp8/global_animal) has announced the addition of the "Global Animal Antimicrobials and Antibiotics Market 2015-2019" report to their offering.
Global Animal Antimicrobials and Antibiotics Market to Grow at a CAGR of 5.25% Over the Period 2014-2019
The key players in the market are increasingly collaborating with academic institutions to develop innovative products for animal healthcare. For instance, in May 2013, Zoetis awarded $100,000 to Texas Tech University to provide resources for salmonella research. The Roslin Institute at the University of Edinburgh and Zoetis collaborated in July 2013 to jointly investigate the entry route, mechanism of persistence in cattle, and beef contamination by salmonella. The BBSRC funded this research. In 2013, Zoetis and the University of Minnesota collaborated to develop a diagnostic test for diseases caused by the porcine epidemic diarrhea virus. In February 2014, the Iowa State University and Zoetis signed a collaborative agreement to develop a vaccine for porcine epidemic diarrhea virus in the US. Such collaborations enable the amalgamation of research expertise of educational institutions with the marketing intelligence of pharma companies besides providing funds to conduct clinical trials.
According to the report, the increasing population is resulting in a rise in the demand for food, including animal-based food. Limited farmlands, moreover, add to the pressure to serve the growing population. Further, increasing urbanization has created a shift in consumption patterns. Nutrient-dense foods such as meat are increasingly consumed when compared to the previous two decades. Rising income levels have also led to an increase in the purchasing of animal proteins, especially among the middle-income groups. Optimizing the yield of animal products such as milk and eggs, therefore, requires the raising of healthy, disease-free animals. This, in turn, has increased the focus of livestock rearers and the food industry on animal medicines to increase the efficiency of feed-to-meat/milk/egg conversion.
Key Topics Covered
- Executive Summary
- List of Abbreviations
- Scope of the Report
- Market Research Methodology
- Introduction
- Veterinary Drug Approval Process
- Market Segmentation by Chemical Class
- Market Segmentation by Type of Animal
- Geographical Segmentation
- Buying Criteria
- Market Growth Drivers
- Drivers and their Impact
- Market Challenges
- Impact of Drivers and Challenges
- Market Trends
- Trends and their Impact
- Vendor Landscape
- Key Vendor Analysis
Companies Mentioned
- Bayer
- Elanco
- Merck Animal Health
- Merial
- Zoetis
- Animal Medics
- Biogenesis Bago
- Biovet
- Boehringer Ingelheim
- Ceva Holdings
- Dechra Pharmaceuticals
- ECO Animal Health
- Huvepharma
- Indian Immunologicals
- Lillidale Animal Health
- Mobedco (The Arab Pesticides Veterinary Drugs)
- Neogen
- Norbrook
- Orion
- Phibro Animal Health
- Vétoquinol
- Virbac
- Vitafor
For more information visit http://www.researchandmarkets.com/research/x2zbp8/global_animal.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150617006460/en/
Contacts:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Animal Healthcare/Veterinary
